Related Experiment Videos
Increased hyaluronidase expression in more aggressive prostate adenocarcinoma
A K Madan1, Y Pang, M B Wilkiemeyer
1Department of Surgery, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Oncology Reports
|October 19, 1999
Summary
Hyaluronidase expression correlates with aggressive features in prostate adenocarcinoma. This enzyme may play a role in tumor progression and metastasis, indicating potential therapeutic targets.
Area of Science:
- Oncology
- Biochemistry
- Pathology
Background:
- Tumor metastasis requires basement membrane penetration.
- Hyaluronidase is implicated in carcinoma development and metastasis.
- Prostate adenocarcinoma progression involves complex cellular events.
Purpose of the Study:
- To correlate hyaluronidase expression with prognostic variables in prostate adenocarcinoma.
- To investigate the role of hyaluronidase in prostate cancer progression.
Main Methods:
- Evaluation of paraffin-embedded prostatectomy samples (n=9) from clinical stage B adenocarcinoma patients.
- Detection of hyaluronidase expression using Reverse Transcription Polymerase Chain Reaction (RT-PCR).
- Correlation of hyaluronidase presence with histological assessments, including Gleason score and invasion patterns.
Main Results:
- Significantly higher Gleason scores in patients with detectable hyaluronidase (7.25 vs. 4.17; p<0.05).
- Perineural invasion observed in 83% of hyaluronidase-positive specimens versus 0% in negative samples (p<0.05).
- A trend towards increased capsular invasion in hyaluronidase-positive tumors (33% vs. 0%).
Conclusions:
- Hyaluronidase expression is associated with more aggressive pathological features in prostate adenocarcinoma.
- These findings suggest hyaluronidase involvement in prostate cancer progression and metastasis.
- Hyaluronidase may represent a potential biomarker or therapeutic target for prostate cancer.